pantoprazole has been researched along with Abdominal Pain in 12 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Abdominal Pain: Sensation of discomfort, distress, or agony in the abdominal region.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this double-blind, placebo-controlled, multicentre study, patients experiencing ulcer-like functional dyspepsia, with epigastric pain as the predominant symptom, were randomised to receive pantoprazole 20 mg or placebo o." | 9.13 | Efficacy and safety of pantoprazole 20 mg once daily treatment in patients with ulcer-like functional dyspepsia. ( Berghöfer, P; Dattani, ID; Enns, R; Fischer, R; Gonzalez Carro, P; Maritz, JF; Schwan, T; van Rensburg, C, 2008) |
| "In this double-blind, placebo-controlled, multicentre study, patients experiencing ulcer-like functional dyspepsia, with epigastric pain as the predominant symptom, were randomised to receive pantoprazole 20 mg or placebo o." | 5.13 | Efficacy and safety of pantoprazole 20 mg once daily treatment in patients with ulcer-like functional dyspepsia. ( Berghöfer, P; Dattani, ID; Enns, R; Fischer, R; Gonzalez Carro, P; Maritz, JF; Schwan, T; van Rensburg, C, 2008) |
| " Eight days before admission she had started and continued to take pantoprazole because of symptoms of gastroesophageal reflux." | 3.72 | [Pantoprazole-induced hepatitis]. ( Cordes, A; Maier, KP; Vogt, W, 2003) |
| "To estimate the rates of common adverse events in patients treated with the proton pump inhibitors omeprazole, lansoprazole and pantoprazole in general practice in England." | 1.31 | The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies. ( Dunn, NR; Freemantle, S; Martin, RM; Shakir, S, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Asharaf, A | 1 |
| Desai, P | 1 |
| Sanati, M | 1 |
| Murthy, RN | 1 |
| Viswanathan, S | 1 |
| Jain, D | 1 |
| Merdassa Roro, G | 1 |
| Sultan Seid, A | 1 |
| Wong, D | 1 |
| Occhipinti, V | 1 |
| Segato, S | 1 |
| Carrara, A | 1 |
| Orlando, S | 1 |
| Conte, D | 1 |
| Aslan, M | 1 |
| Celik, Y | 1 |
| Karadas, S | 1 |
| Olmez, S | 1 |
| Cifci, A | 1 |
| Çekin, AH | 1 |
| Şahintürk, Y | 1 |
| Akbay Harmandar, F | 1 |
| Uyar, S | 1 |
| Yolcular, BO | 1 |
| Çekin, Y | 1 |
| van Rensburg, C | 1 |
| Berghöfer, P | 1 |
| Enns, R | 1 |
| Dattani, ID | 1 |
| Maritz, JF | 1 |
| Gonzalez Carro, P | 1 |
| Fischer, R | 1 |
| Schwan, T | 1 |
| Cho, SW | 1 |
| Hwang, JT | 1 |
| Oh, TH | 1 |
| Cordes, A | 1 |
| Vogt, W | 1 |
| Maier, KP | 1 |
| Wellhöfer, B | 1 |
| Dammann, HG | 1 |
| Fölsch, UR | 1 |
| Hahn, EG | 1 |
| von Kleist, DH | 1 |
| Klör, HU | 1 |
| Kirchner, T | 1 |
| Strobel, S | 1 |
| Kist, M | 1 |
| Martin, RM | 1 |
| Dunn, NR | 1 |
| Freemantle, S | 1 |
| Shakir, S | 1 |
3 trials available for pantoprazole and Abdominal Pain
| Article | Year |
|---|---|
Use of probiotics as an adjuvant to sequential H. pylori eradication therapy: impact on eradication rates, treatment resistance, treatment-related side effects, and patient compliance.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adult; Amoxicillin; Anorexia; Anti-Bacteria | 2017 |
Efficacy and safety of pantoprazole 20 mg once daily treatment in patients with ulcer-like functional dyspepsia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adolescent; Adult; Aged; Anti-Ulcer Agents; | 2008 |
Eradication of H. pylori with pantoprazole, clarithromycin, and metronidazole in duodenal ulcer patients: a head-to-head comparison between two regimens of different duration.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adult; Aged; Anti-Bacterial Agents; Anti-Ul | 2000 |
9 other studies available for pantoprazole and Abdominal Pain
| Article | Year |
|---|---|
Emphysematous Gastritis.
Topics: Abdominal Pain; Anti-Bacterial Agents; Anti-Ulcer Agents; Emphysema; Foreign Bodies; Gastritis; Huma | 2019 |
Multiple ecchymotic signs in acute pancreatitis.
Topics: Abdomen; Abdominal Pain; Acute Disease; Adult; Analgesics, Opioid; Drug Therapy, Combination; Ecchym | 2020 |
Gastric Outlet Obstruction Caused by a Tapeworm: An Uncommon Presentation of a Common Parasite.
Topics: Abdominal Pain; Adult; Animals; Anthelmintics; Ethiopia; Gastric Outlet Obstruction; Gastroscopy; Hu | 2020 |
ERCP or NO ERCP: the case report of a frail patient.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Aged; Angiotensin-Converting Enzyme Inhibit | 2018 |
Liver hepatotoxicity associated with pantoprazole: a rare case report.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Anti-Ulcer Agents; Chemical and Drug Induce | 2014 |
Education and imaging. Gastrointestinal: Scrub typhus induced acute gastric ulceration.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Acute Disease; Aged; Anti-Bacterial Agents; | 2010 |
[Pantoprazole-induced hepatitis].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdomen; Abdominal Pain; Anti-Ulcer Agents; Benzimidazoles; | 2003 |
[Pantoprazole-induced hepatitis].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Anti-Ulcer Agents; Benzimidazoles; Chemical | 2003 |
The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adult; Adverse Drug Reaction Reporting Syst | 2000 |